HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John M Pagel Selected Research

brexucabtagene autoleucel

1/2023Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study.
1/2021KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results.
1/2020KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John M Pagel Research Topics

Disease

43Neoplasms (Cancer)
11/2023 - 03/2003
37B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2023 - 10/2012
32Lymphoma (Lymphomas)
12/2021 - 03/2003
26Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2023 - 03/2006
23Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2021 - 03/2003
21B-Cell Lymphoma (Lymphoma, B Cell)
01/2023 - 03/2003
17Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 01/2005
13Leukemia
12/2020 - 02/2008
12Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2023 - 12/2009
12Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2023 - 06/2008
8Residual Neoplasm
01/2023 - 11/2010
7Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 10/2007
6Disease Progression
01/2022 - 06/2008
5Diarrhea
12/2021 - 01/2015
5Neutropenia
12/2021 - 01/2015
5Myeloid Leukemia (Leukemia, Myelocytic)
12/2020 - 05/2007
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 01/2020
4Pneumonia (Pneumonitis)
01/2022 - 01/2015
4Multiple Myeloma
01/2022 - 02/2014
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 03/2011
4Hodgkin Disease (Hodgkin's Disease)
01/2021 - 09/2008
3Colitis
01/2022 - 01/2015
3Tumor Lysis Syndrome
12/2021 - 01/2018
3Thrombocytopenia (Thrombopenia)
01/2021 - 01/2015
3Graft vs Host Disease (Graft-Versus-Host Disease)
01/2016 - 08/2010
2Infections
10/2021 - 01/2020
2AIDS-Related Complex (ARC)
01/2021 - 12/2019
2Pathologic Complete Response
02/2015 - 11/2012
2Burkitt Lymphoma (Burkitt's Lymphoma)
01/2015 - 03/2003
2Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
06/2011 - 09/2005
1Lymphoid Leukemia
11/2023

Drug/Important Bio-Agent (IBA)

14Agammaglobulinaemia Tyrosine KinaseIBA
11/2023 - 01/2016
14Rituximab (Mabthera)FDA Link
01/2022 - 05/2004
13Radioisotopes (Radionuclides)IBA
01/2021 - 07/2006
11procaine isothiocyanate (PRIT)IBA
12/2020 - 06/2007
10StreptavidinIBA
01/2015 - 04/2006
10AntibodiesIBA
10/2012 - 03/2003
9venetoclaxIBA
11/2023 - 01/2016
9Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2006
9acalabrutinibIBA
01/2022 - 01/2016
9ibrutinibIBA
01/2022 - 01/2016
9fludarabineIBA
01/2021 - 12/2009
9Monoclonal AntibodiesIBA
01/2020 - 05/2004
9Biotin (Vitamin H)FDA Link
01/2015 - 03/2003
7Cytarabine (Cytosar-U)FDA LinkGeneric
11/2023 - 11/2012
7Chimeric Antigen ReceptorsIBA
01/2023 - 09/2008
7DOTA-biotin (90Y-DOTA-biotin)IBA
12/2020 - 03/2003
6Immunoconjugates (Immunoconjugate)IBA
10/2020 - 06/2007
5idelalisibIBA
01/2021 - 03/2014
4Phosphotransferases (Kinase)IBA
01/2021 - 10/2015
4AntigensIBA
12/2019 - 06/2007
3Iodine-131IBA
11/2023 - 09/2014
3brexucabtagene autoleucelIBA
01/2023 - 01/2020
3Chlorambucil (Leukeran)FDA Link
01/2022 - 04/2015
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2022 - 01/2015
3obinutuzumabIBA
01/2022 - 04/2015
3umbralisibIBA
12/2021 - 01/2021
3Etoposide (VP 16)FDA LinkGeneric
01/2021 - 04/2013
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020 - 03/2006
3FenretinideIBA
01/2017 - 05/2004
31,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2015 - 03/2003
3Indicators and Reagents (Reagents)IBA
01/2015 - 06/2007
3GalactosamineIBA
07/2010 - 07/2006
3HLA-DR Antigens (HLA-DR)IBA
05/2009 - 06/2007
2pirtobrutinibIBA
11/2023 - 01/2021
2axicabtagene ciloleucelIBA
01/2023 - 01/2022
2Phosphatidylinositols (Phosphatidylinositol)IBA
12/2021 - 01/2021
2Transaminases (Aminotransferases)IBA
12/2021 - 01/2019
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2021 - 04/2015
2duvelisibIBA
12/2020 - 11/2019
2Bendamustine HydrochlorideFDA Link
11/2020 - 08/2014
2Tyrosine Kinase InhibitorsIBA
01/2020 - 12/2019
2RetinoidsIBA
01/2017 - 10/2015
2tositumomab I-131 (Bexxar)FDA Link
01/2016 - 12/2012
2Clofarabine (Clolar)FDA Link
08/2015 - 04/2015
2Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
06/2015 - 08/2014
2ibritumomab tiuxetan (Zevalin)FDA Link
02/2015 - 07/2011
2TRU 016IBA
01/2015 - 02/2014
2treosulfanIBA
04/2014 - 03/2011
2Carboplatin (JM8)FDA LinkGeneric
04/2013 - 08/2010
2Surface Antigens (Surface Antigen)IBA
05/2009 - 06/2007
2AcetylgalactosamineIBA
05/2009 - 09/2007
2Leukocyte Common Antigens (CD45 Antigen)IBA
01/2009 - 08/2008
2AcidsIBA
09/2007 - 06/2007
2CaspasesIBA
07/2005 - 05/2004
1Histone Deacetylase InhibitorsIBA
11/2023
1dinaciclibIBA
01/2022

Therapy/Procedure

52Therapeutics
01/2023 - 07/2005
30Radioimmunotherapy
12/2020 - 03/2003
28Cell Transplantation
11/2023 - 01/2005
16Drug Therapy (Chemotherapy)
11/2023 - 09/2007
10Stem Cell Transplantation
01/2023 - 04/2007
9Homologous Transplantation
02/2015 - 07/2006
7Immunotherapy
01/2021 - 05/2008
5Transplantation
09/2014 - 06/2008
4Radiotherapy
01/2015 - 09/2007
4Hematopoietic Stem Cell Transplantation
05/2013 - 04/2007
3Autologous Transplantation
01/2020 - 07/2006
2Induction Chemotherapy
10/2021 - 06/2008
2Consolidation Chemotherapy
01/2020 - 02/2015